Evidence map›Paper›PMID 33198311›Full record

ArticleAntibiotics (Basel, Switzerland)2020

Detection of Low-Level Fosfomycin-Resistant Variants by Decreasing Glucose-6-Phosphate Concentration in Fosfomycin Susceptibility Determination.

Guillermo Martín-Gutiérrez, Fernando Docobo-Pérez, Jose Manuel Rodríguez-Martínez, Alvaro Pascual, Jesús Blázquez, Jeronimo Rodriguez-Beltrán

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Description of a chromosomalAntimicrobial agents and chemotherapy · 2026
    Article
  2. Inactivation ofMicrobiology spectrum · 2023
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Guillermo Martín-GutiérrezUnidad de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen del Rocio, 41013 Seville, Spain.ORCID 0000-0002-3456-9532
Fernando Docobo-PérezInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Seville, Spain.ORCID 0000-0003-4038-6764
Jose Manuel Rodríguez-MartínezInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Seville, Spain.ORCID 0000-0002-2228-2294
Alvaro PascualInstituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Seville, Spain.
Jesús BlázquezRed Española de Investigación en Patología Infecciosa (REIPI), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Jeronimo Rodriguez-BeltránDepartment of Microbiology, Hospital Universitario Ramon y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.
Instituto de Salud Carlos III · ESConsejo Superior de Investigaciones Científicas · ESInstituto de Biomedicina de Sevilla · ES

Funding

Instituto de Salud Carlos III REIPI RD16/0016/0009
6 · The paper itself

Abstract

Mutations that confer low-level fosfomycin resistance (LLFR) but not clinical resistance in

Indexed as

Escherichia colifosfomycin resistanceglucose-6-phosphateMICurinary tract infection

Identifiers

PMID33198311
PMCPMC7698254
OpenAlexW3098044308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.